The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 360:187-189 January 8, 2009 Number 2
NextNext

Defibrillators in Heart Failure and Quality of Life

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Poole, J. E.
-Related Article
by Mark, D. B.
-PubMed Citation
To the Editor: Mark et al. (Sept. 4 issue)1 report data on quality of life from the well-designed Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). These data call for a repeat cost-effectiveness analysis of the use of implantable cardioverter–defibrillators (ICDs) for the primary prevention of death from cardiac causes. The newly reported utilities were 0.80 at baseline and 0.70 at 30 months. Mark et al. did not report these utilities in their previous cost-effectiveness analysis.2 In contrast, a separate cost-effectiveness analysis assumed a utility of 0.88 and showed ICDs to be cost-effective.3 The application of these new utilities to . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.